Citigroup Inc ARRIVENT BIOPHARMA INC Transaction History

Citigroup Inc

  • $196 Billion
  • Q2 2025
Number of Shares
21,567
Previous 34,169 36.88%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
N/A
-12,602 Reduced 36.88%
21,567 $0
Q1 2025

May 12, 2025
BUY
N/A
48 Added 0.14%
34,169 $0
Q4 2024

Feb 12, 2025
BUY
N/A
13,721 Added 67.26%
34,121 $0
Q3 2024

Nov 12, 2024
BUY
N/A
18,237 Added 843.13%
20,400 $0
Q2 2024

Aug 12, 2024
BUY
N/A
422 Added 24.24%
2,163 $0
Q1 2024

May 10, 2024
BUY
N/A
1,741 New
1,741 $0
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email